Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary shares
-
Shares outstanding
-
49,942,911
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
16,654,128
-
Shares change
-
+2,269,420
-
Total reported value, excl. options
-
$617,381,000
-
Value change
-
+$83,084,443
-
Number of buys
-
21
-
Number of sells
-
-12
-
Price
-
$37.07
Significant Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q3 2021
50 filings reported holding IMCR - Immunocore Holdings plc - Ordinary shares as of Q3 2021.
Immunocore Holdings plc - Ordinary shares (IMCR) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,654,128 shares
of 49,942,911 outstanding shares and own 33.35% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (2,520,730 shares), Rock Springs Capital Management LP (2,445,155 shares), FMR LLC (2,180,985 shares), RTW INVESTMENTS, LP (1,245,532 shares), Avidity Partners Management LP (1,095,600 shares), WELLINGTON MANAGEMENT GROUP LLP (1,052,075 shares), GENERAL ATLANTIC, L.P. (950,000 shares), BlackRock Inc. (827,604 shares), Bain Capital Public Equity Management II, LLC (638,205 shares), and Bill & Melinda Gates Foundation (576,923 shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.